Genetic Variant of DNAM-1 rs763361 C>T Is Associated with Ankylosing Spondylitis in a Mexican Population

Alejandro Vázquez-Reyes,José Francisco Zambrano-Zaragoza,Juan Manuel Agraz-Cibrián,Miriam Fabiola Ayón-Pérez,Gloria Yareli Gutiérrez-Silerio,Susana Del Toro-Arreola,Alan Guillermo Alejandre-González,Liliana Ortiz-Martínez,Jesse Haramati,Iris Celeste Tovar-Ocampo,Marcelo Victorio-De los Santos,Jorge Gutiérrez-Franco

DOI: https://doi.org/10.3390/cimb46040176

2024-03-23

Current Issues in Molecular Biology

Abstract:DNAM-1 (CD226) is an activating receptor expressed in CD8+ T cells, NK cells, and monocytes. It has been reported that two SNPs in the DNAM-1 gene, rs763361 C>T and rs727088 G>A, have been associated with different autoimmune diseases; however, the role of DNAM-1 in ankylosing spondylitis has been less studied. For this reason, we focused on the study of these two SNPs in association with ankylosing spondylitis. For this, 34 patients and 70 controls were analyzed using endpoint PCR with allele-specific primers. Our results suggest that rs763361 C>T is involved as a possible protective factor under the CT co-dominant model (OR = 0.34, 95% CI = 0.13–0.88, p = 0.022) and the CT + TT dominant model (OR = 0.39, 95% CI = 0.17–0.90, p = 0.025), while rs727088 G>A did not show an association with the disease in any of the inheritance models. When analyzing the relationships of the haplotypes, we found that the T + A haplotype (OR = 0.31, 95% CI = 0.13–0.73, p = 0.0083) is a protective factor for developing the disease. In conclusion, the CT and CT + TT variants of rs763361 C>T and the T + A haplotype were considered as protective factors for developing ankylosing spondylitis.

biochemistry & molecular biology